نتایج جستجو برای: aβ1

تعداد نتایج: 893  

2015
Michael T. Colvin Robert Silvers Birgitta Frohm Yongchao Su Sara Linse Robert G. Griffin

The presence of amyloid plaques composed of amyloid beta (Aβ) fibrils is a hallmark of Alzheimer's disease (AD). The Aβ peptide is present as several length variants with two common alloforms consisting of 40 and 42 amino acids, denoted Aβ1-40 and Aβ1-42, respectively. While there have been numerous reports that structurally characterize fibrils of Aβ1-40, very little is known about the structu...

2015
Shima Mehrabian Panagiotis Alexopoulos Marion Ortner Latchezar Traykov Timo Grimmer Alexander Kurz Hans Förstl Horst Bickel Janine Diehl-Schmid

INTRODUCTION Cerebrospinal fluid (CSF) biomarkers improve the diagnostic accuracy for Alzheimer's disease (AD), even at the predementia stage of the disease. The ε4-allele of apolipoprotein E (ApoE ε4), female sex, and older age are well-known risk factors for AD. It is unclear how these risk factors affect the CSF biomarkers in patients with AD. AIM The objective of this study was to investi...

Journal: :Alzheimers & Dementia 2023

Background Cerebrospinal fluid (CSF) Aβ1-42 and the Aβ1-42/Aβ1-40 ratio are markers of amyloid pathology. We aimed to compare their agreement in different neurodegenerative disorders applying cutoffs. Method included 1564 participants from Sant Pau Initiative on Neurodegeneration (SPIN), with AD, dementia Lewy bodies (DLB), frontotemporal lobar degeneration-related syndromes (FTLD), cognitively...

2016
Rui Gao Guangjian Zhang Xueqi Chen Aimin Yang Gwenn Smith Dean F. Wong Yun Zhou

OBJECTIVE Cerebrospinal fluid (CSF) biomarkers, such as α-synuclein (α-syn), amyloid beta peptide 1-42 (Aβ1-42), phosphorylated tau (181P) (p-tau), and total tau (t-tau), have long been associated with the development of Parkinson disease (PD) and other neurodegenerative diseases. In this investigation, we reported the assessment of CSF biomarkers and their correlations with vesicular monoamine...

2018
Ross W. Paterson Catherine F. Slattery Teresa Poole Jennifer M. Nicholas Nadia K. Magdalinou Jamie Toombs Miles D. Chapman Michael P. Lunn Amanda J. Heslegrave Martha S Foiani Philip S. J. Weston Ashvini Keshavan Jonathan D. Rohrer Martin N. Rossor Jason D. Warren Catherine J. Mummery Kaj Blennow Nick C. Fox Henrik Zetterberg Jonathan M. Schott

BACKGROUND Cerebrospinal fluid (CSF) biomarkers are increasingly being used to support a diagnosis of Alzheimer's disease (AD). Their clinical utility for differentiating AD from non-AD neurodegenerative dementias, such as dementia with Lewy bodies (DLB) or frontotemporal dementia (FTD), is less well established. We aimed to determine the diagnostic utility of an extended panel of CSF biomarker...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2015
Marjana Brkic Sriram Balusu Elien Van Wonterghem Nina Gorlé Iryna Benilova Anna Kremer Inge Van Hove Lieve Moons Bart De Strooper Selma Kanazir Claude Libert Roosmarijn E Vandenbroucke

UNLABELLED The blood-CSF barrier (BCSFB) consists of a monolayer of choroid plexus epithelial (CPE) cells that maintain CNS homeostasis by producing CSF and restricting the passage of undesirable molecules and pathogens into the brain. Alzheimer's disease is the most common progressive neurodegenerative disorder and is characterized by the presence of amyloid β (Aβ) plaques and neurofibrillary ...

2017
Christopher M. Siwy Christopher Lockhart Dmitri K. Klimov

By applying REMD simulations we have performed comparative analysis of the conformational ensembles of amino-truncated Aβ10-40 peptide produced with five force fields, which combine four protein parameterizations (CHARMM36, CHARMM22*, CHARMM22/cmap, and OPLS-AA) and two water models (standard and modified TIP3P). Aβ10-40 conformations were analyzed by computing secondary structure, backbone flu...

Journal: :Alzheimer's & dementia : the journal of the Alzheimer's Association 2013
Vanessa A Guzman Owen T Carmichael Christopher Schwarz Giuseppe Tosto Molly E Zimmerman Adam M Brickman

BACKGROUND Current hypothetical models of Alzheimer's disease (AD) pathogenesis emphasize the role of β-amyloid (Aβ), tau deposition, and neurodegenerative changes in the mesial temporal lobe, particularly the entorhinal cortex and hippocampus. However, many individuals with clinical AD who come to autopsy also exhibit cerebrovascular disease. The relationship between AD and vascular pathology ...

2011
Toshio Ariga Chandramohan Wakade Robert K. Yu

Conversion of the soluble, nontoxic amyloid β-protein (Aβ) into an aggregated, toxic form rich in β-sheets is a key step in the onset of Alzheimer's disease (AD). It has been suggested that Aβ induces changes in neuronal membrane fluidity as a result of its interactions with membrane components such as cholesterol, phospholipids, and gangliosides. Gangliosides are known to bind Aβ. A complex of...

2016
Xinhua Zhan Boryana Stamova Lee-Way Jin Charles DeCarli Brett Phinney Frank R. Sharp

OBJECTIVE We determined whether Gram-negative bacterial molecules are associated with Alzheimer disease (AD) neuropathology given that previous studies demonstrate Gram-negative Escherichia coli bacteria can form extracellular amyloid and Gram-negative bacteria have been reported as the predominant bacteria found in normal human brains. METHODS Brain samples from gray and white matter were st...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید